Results

Total Results: 2,228 records

Showing results for "disease".

421. Comparative Effectiveness Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/osteoarthritis-pain-2006_appendixes.pdf
     January 01, 2006 - , cancer of mental disturbance; any disease that could potentially interfere with the evaluation of … analgesics, warfarin, ticlopidine, high-dose aspirin, appetite suprossants, other meds for chronic diseases … January 1, 1992 and October 31, 1997; ≤ 75 years of age; free of metabolic or cardiovascular diseases … within 2 yrs; active hepatic disease; recent neoplastic disease; acute meniscal injury to the study … gastroduodenal ulcer or GI bleedind; history of alcohol of other drug abuse; lactationl concomitant skin diseases

422. Slide 1
     effectivehealthcare.ahrq.gov/sites/default/files/comparator-selection-in-observational-chapter-5.pptx
     January 01, 2013 - Treatment decisions are based on factors associated with underlying disease and its severity, general … Treatment decisions are based on numerous factors associated with the underlying disease and its severity … The treatment of unrelated disorders in patients with chronic medical diseases. … surgery might be reserved for those with more severe disease. … , and surgery might be reserved for those with more severe disease.

423. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/pressure-ulcer-prevention_research-protocol.pdf
     January 10, 2012 - status; incontinence; or specific medical comorbidities, such as diabetes or peripheral vascular disease … Published Online: January 10, 2012 6 comorbidities (e.g., diabetes and peripheral vascular disease … [mp=protocol supplementary concept, rare disease supplementary concept, title, original title, abstract … [mp=protocol supplementary concept, rare disease supplementary concept, title, original title, abstract … [mp=protocol supplementary concept, rare disease supplementary concept, title, original title, abstract

424. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests_executive.pdf
     February 01, 2006 - women would be newly diagnosed as having breast cancer and there would be 40,870 deaths due to this disease … Notes: Sensitivity is the probability that a test is positive in those with the disease. … Specificity is the probability that a test is negative in those without the disease. … cancer to the probability of a negative test in women without cancer; based on the risk of having the disease … prior to the test, it is used to calculate the risk of having the disease despite a negative test result

425. AHRQ’s Evidence-based Practice Center Program Annual Report 2023 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/pdf/epc-year-in-review-2023.pdf
     January 01, 2023 - Cervical Degenerative Disease Treatment: A Systematic Review 2. … Radiation Therapy for Metastatic Bone Disease: Effectiveness and Harms 18. … Cervical Degenerative Disease Treatment. … Dental Care for Persons With Sickle Cell Disease 8. … Centers for Disease Control and Prevention (CDC) 4.

426. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/11_peptic_ulcer_potential_high_impact_2012-12-111.pdf
     January 01, 2012 - (e.g., Crohn’s disease, ulcerative colitis [UC]). … (The therapy has also recently been identified as being explored for other autoimmune diseases such … The rationale for this treatment stems from observing that inflammatory bowel diseases are rare in … National Digestive Diseases Information Clearinghouse (NDDIC). … National Digestive Diseases Information Clearinghouse. Short bowel syndrome. [internet].

427. Colorectal-Cancer-Liver-Metastases-Therapies Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-liver-metastases-therapies_executive.pdf
     December 01, 2012 - sections that follow, we describe CRC and its diagnosis and treatment to orient the reader to the disease … For the 20 percent of patients who are initially diagnosed with distant (i.e., metastatic) disease, … Treatment of Localized Disease For the 39 percent of patients who are diagnosed with localized disease … ., they have experienced disease progression while on therapy). … is refractory (i.e., they have experienced disease progression while on therapy)

428. Effectiveness of Screening and Treatment of Subclinical Hypothyroidism or Hyperthyroidism (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hypothyroidism-hyperthyroidism-screening-treatment_disposition-comments.pdf
     February 01, 2012 - While AHRQ and the USPSTF defined screening for undetected overt thyroid disease as outside the scope … that about 1% of unselected primary care patients have symptomatic, but undetected overt thyroid disease … asking them periodically if they have progression of a specific issue relevant to their diagnosed disease … We did not include any original articles with patients with known thyroid disease. … , without history of known overt thyroid disease, drawn from settings other than primary care.

429. Vitamin-D-Calcium-Protocol-130611 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/vitamin-d-calcium_research-protocol.pdf
     September 13, 2013 - part on increasing interest in the potential roles of calcium and vitamin D in preventing chronic disease … for diseases. … o For clinical outcomes of cardiovascular disease (CVD), only studies of adults will be included (≥18 …  Autoimmune diseases  Infectious disease-specific mortality o Pregnancy-related outcomes  … , autoimmune diseases, infectious disease-specific mortality) • Pregnancy-related clinical and intermediate

430. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/c-diff-infections_executive.pdf
     December 01, 2011 - (a) Does effectiveness vary by disease severity or strain? … Four studies found use of alcohol gels as interventions for other infectious diseases, presumably in … formulation of a probiotic that can effectively target alterations in the microbiome in CDI and other diseases … Centers for Disease Control and Prevention. … European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations

431. Chicago-Area DEcIDE Center (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/off-label-use-research-priorities_research.pdf
     May 01, 2009 - Nationally representative prescribing data from the IMS Health (Plymouth Meeting PA) National Disease … The only notable exception was the use of warfarin in coronary artery disease. … National Disease and Therapeutic Index, Medication Reference File, 2001. … A comparison of the National Disease and Therapeutic Index and the National Ambulatory Medical Care … International Classification of Diseases, Ninth Revision, Clinical Modification.

432. Identification and Treatment of Post-Acute Coronary Syndrome (ACS) Depression: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/acs-depression-research-protocol-amended.pdf
     February 15, 2017 - included: (a) clarifying the screening tools to be considered and how International Classification of Diseases … Global status report on noncommunicable diseases 2014. … Centers for Disease Control and Prevention (CDC). Heart Disease Facts, 2015. … Food and Drug Administration GI Gastrointestinal ICD International Classification of Diseases KQ … Duloxetine Yes Hypertension Levomilnacipran4 Yes Cerebrovascular disease, Cardiovascular disease

433. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-update_executive.pdf
     March 01, 2011 - insulin secretion by pancreatic beta cells, leading to chronic hyperglycemia and associated long-term disease … Long-term complications of diabetes include microvascular disease, such as retinopathy and blindness, … neuropathy, nephropathy, and end-stage kidney disease. … In addition, the death rate from cardiovascular disease in adults with type 2 diabetes is two to four … Diabetes Care 2006; 29(6):1263-1268. 2 National Institute of Diabetes and Digestive and Kidney Diseases

434. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - National Digestive Diseases Information Clearinghouse (NDDIC). Irritable bowel syndrome. … Bethesda (MD): National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); 2013 Sep … Available: http://www.mayoclinic.org/diseases- conditions/irritable-bowel- syndrome/basics/definition … /irritable-bowel-syndrome/basics/definition/CON-20024578 http://www.mayoclinic.org/diseases-conditions … /irritable-bowel-syndrome/basics/definition/CON-20024578 http://www.mayoclinic.org/diseases-conditions

435. Restless-Legs Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/restless-legs_executive.pdf
     November 01, 2012 - Periods of remission are common, particularly in younger patients and those with milder disease. … We evaluated RLS symptom severity and outcome, patient-reported sleep quality, and disease-specific … Mean RLS disease duration was 12 years. … No RCTs assessed patients with mild or moderate disease, and few lasted longer than 6 months. … Severity of disease • Clinical trials include patients with moderate to very severe disease typically

436. Assessing Applicability (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/assessing-applicability.ppt
     January 01, 2009 - prevalence in study population different than community Prevalence of disease (for diagnostic studies … Finally, evaluate the prevalence of the disease in diagnostic test studies. … If the disease prevalence is markedly different than in the community, then applicability is reduced. … This is especially true in diseases that afflict patients with lower compliance rates such as abusers … In this example, we focus on the age of patients with a disease.

437. Assessing Applicability (ppt file)
     effectivehealthcare.ahrq.gov/sites/default/files/assessing-applicability.ppt
     January 01, 2009 - prevalence in study population different than community Prevalence of disease (for diagnostic studies … Finally, evaluate the prevalence of the disease in diagnostic test studies. … If the disease prevalence is markedly different than in the community, then applicability is reduced. … This is especially true in diseases that afflict patients with lower compliance rates such as abusers … In this example, we focus on the age of patients with a disease.

438. EHC Protocol - Allocation of Scarce Resources During Pandemics: Strategies for Policy Makers: A Rapid Evidence Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/scarce-resources-protocol.pdf
     January 01, 2013 - tiab] OR "emergency planning" OR "emergency preparedness" OR mass casualt* OR pandemic OR epidemic OR disease … SCIENCE CATEGORIES: ( PUBLIC ENVIRONMENTAL OCCUPATIONAL HEALTH OR MEDICAL INFORMATICS OR INFECTIOUS DISEASES … OR "emergency planning" OR "emergency preparedness" OR "mass casualt*" OR pandemic OR epidemic OR "disease … OR "emergency planning" OR "emergency preparedness" OR "mass casualt*" OR pandemic OR epidemic OR "disease … outbreak*")):ti,ab,kw OR MeSH descriptor: [Disasters] explode all trees OR MeSH descriptor: [Disease

439. PowerPoint Presentation (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/krishnan_ahrq-mcda-presentation.pdf
     August 27, 2012 - Chronic obstructive pulmonary disease (COPD) as a key health condition. 2. … Analytic hierarchy process to establish priorities. 2 Chronic Obstructive Pulmonary Disease … common lung disorder • 24,000,000 persons – 3rd leading cause of death • Deaths rising • Heart disease … hospital readmissions – $49.9 billion / yr NHLBI Chartbook 3 Chronic Obstructive Pulmonary Disease

440. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/weight-gain-prevention_research-protocol.pdf
     January 01, 2020 - Morbidity and Mortality Obesity is a risk factor for chronic conditions including cardiovascular disease … , diabetes, cardiovascular disease, cancer, liver disease, or death … Obesity-related clinical outcomes • Mortality • Cancer • Cardiovascular disease • Sub-fertility … • Diabetes • Degenerative joint disease • Liver disease • Quality of life Adverse effects … Multiple risk factors for cardiovascular disease and diabetes mellitus.